CORIUM INTERNATIONAL
Corium International is a privately-owned company engaged in the research, development and manufacture of advanced transdermal drug delivery technologies and products. Using its proprietary delivery technologies and its development and manufacturing expertise, Corium has developed a number of active and passive transdermal products with enhanced therapeutic or safety profiles. This self-funded product pipeline spans several therapeutic areas and is in various stages of development. Corium also has several partner-funded products with small, medium and large pharmaceutical companies in various stages of development, ranging from manufacturing to research and development.
CORIUM INTERNATIONAL
Industry:
Biotechnology Health Care Manufacturing Pharmaceutical
Founded:
1995-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.coriumgroup.com
Total Employee:
501+
Status:
Active
Contact:
(650)298-8255
Total Funding:
320 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS DocuSign ATT
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2007-09-27 | StrataGent Life Sciences | StrataGent Life Sciences acquired by Corium International | N/A |
Investors List
Hercules Capital
Hercules Capital investment in Debt Financing - Corium International
CRG
CRG investment in Convertible Note - Corium International
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners investment in Series C - Corium International
Aphelion Capital
Aphelion Capital investment in Series C - Corium International
Quantum Technology Partners
Quantum Technology Partners investment in Series C - Corium International
Official Site Inspections
http://www.coriumgroup.com
- Host name: 104.37.84.6
- IP address: 104.37.84.6
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Corium International" on Search Engine
Corium International - Crunchbase Company Profile & Funding
Operating Status Active. Last Funding Type Debt Financing. Stock Symbol NASDAQ:CORI. Company Type For Profit. Phone Number (650)298-8255. Corium International is a privately-owned company engaged in the research, development and manufacture of advanced transdermal drug delivery technologies and products.See details»
Gurnet Point Capital Completes Acquisition of Corium International…
Nov 27, 2018 As a result of the merger, Corium shares will no longer be traded on the Nasdaq Global Stock Market, and Corium will become a wholly-owned, privately-held subsidiary of Gurnet Point L.P. The Company plans to maintain operations in the Menlo Park, CA and Grand Rapids, MI areas.See details»
Corium Inc. – Solutions that transform care
Solutions That. Transform Care. Corium is a commercial-stage biopharmaceutical company leading the development and commercialization of novel neuroscience therapies that provide clinicians with important treatment options for …See details»
Corium International Company Profile 2024: Valuation, Funding ...
Corium International Overview. Update this profile. Year Founded. 1996. Status. Private. Employees. 487. Latest Deal Type. Debt. Financing Rounds. 10. Investments. 1. General Information. Description. Developer of drug delivery technologies and products based in Grand Rapids, Michigan.See details»
Corium International snapped up by US PE firm Gurnet Point …
Oct 12, 2018 Corium, a commercial-stage biopharmaceutical company, expects to close the deal by 2018-end, after which the company will offer to repurchase all of its $120 million in convertible notes. Following deal completion, Corium will become private and will cease trading on the Nasdaq Global Select Market.See details»
Corium International: Will This Stellar Growth Company Continue …
Feb 21, 2018 The Menlo Park, CA, based firm, Corium International is focusing on the development and commercialization of therapeutics to service the specialty pharma market. Corium’s approved products...See details»
Corium Internation (CORI) to be Acquired by Gurnet Point Capital …
Oct 11, 2018 Corium International, Inc. (Nasdaq: CORI ), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products,...See details»
Gurnet Point Capital acquires Corium International - Crunchbase
Oct 11, 2018 Overview. Acquired Organization: Corium International Corium International engages in the development of advanced transdermal drug delivery technologies and products. Acquiring Organization: Gurnet Point Capital Gurnet Point Capital is a private equity firm that invests in de-risked life sciences companies. …See details»
Corium Inc. – Delivering Innovative Transdermal Solutions
Corium Inc. – Delivering Innovative Transdermal Solutions. Therapeutic Areas of Focus. Our Products. Publications & Presentations. Corium is committed to developing novel therapies that have the potential to treat neuroscience disorders. ADHD.See details»
Corium Inc. – Delivering Innovative Transdermal Solutions
Boston, MA, August 1, 2022 — Corium, Inc., a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS) therapies, announced today that both strengths of its new once-weekly ADLARITY (donepezil transdermal system) maintain equivalent daily exposure of donepezil when …See details»
Corium International - Funding, Financials, Valuation & Investors
Corium International is registered under the ticker NASDAQ:CORI . Their stock opened with $8.00 in its Apr 3, 2014 IPO. Corium International is funded by 5 investors. Hercules Capital and CRG are the most recent investors. Corium International has acquired StrataGent Life Sciences on Sep 26, 2007.See details»
Corium International, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Corium International, Inc. with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, 25 news, and 8 literature, Disease Domain:Endocrinology and Metabolic Disease, Nervous System Diseases, Technology Platform:Small molecule drug, Recombinant polypeptide, Drug:Donepezil Hydrochloride, Teriparatide transdermal ...See details»
Corium Distribution
Corium Distribution stands at the forefront of delivering critical supplies to governments, corporations, and organizations worldwide. With our headquarters based in London, England, and additional offices in Washington DC, USA, we've established a global presence, collaborating closely with partners across Asia, Europe, the Middle East, and ...See details»
Corium International - Products, Competitors, Financials, …
Corium International is a company that focuses on advanced transdermal delivery systems and related technologies in the medical sector. The company offers two main technologies: a biodegradable microstructure patch for active delivery of proteins, peptides, and vaccines, and a novel adhesive system and patch for delivery of small molecules.See details»
Corium Pharma Solutions, Inc. is Now Corium Innovations, Inc ...
GRAND RAPIDS, Mich., June 6, 2023 /PRNewswire/ -- Corium Pharma Solutions, Inc., a leading, full-service contract development and manufacturing organization ("CDMO"), today announced its new...See details»
Corium International - Contacts, Employees, Board Members, …
Corium International. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Employee Profiles 3. Contacts 148. About. Corium International has 3 current employee profiles, including Founder, President and CTO Gary W. Cleary. Contacts. Job Department. Protected Content. CEO. Executive Management.See details»
QUEBEC AI INNOVATION: COGINOV AND CORIUM JOIN …
LONGUEUIL, QC, Jan. 22, 2024 /CNW/ - COGINOV, a Canadian leader in semantic technologies and document & records management, continues its expansion into international markets with the...See details»
Corium Inc. – Delivering Innovative Transdermal Solutions
Our Mission & Values. The leadership team at Corium brings together industry-leading experts in drug development, manufacturing, and commercialization who are dedicated to doing more for our partners and patients. Perry Sternberg, President and …See details»
Corium Inc. – Delivering Innovative Transdermal Solutions
Our Mission & Values. Leadership. Board of Directors. Our Mission & Values. To create and deliver innovative solutions that transform care for patients, their families, and their caregivers. Our Values. At Corium, our culture is core to who we are.See details»
Teriparatide transdermal - Corium International - AdisInsight
Sep 6, 2017 Buy a PDF version of the profile. Request a free trial. A transdermal formulation of the active pharmaceutical ingredient (API) present in Eli Lilly's Forteo® [see Adis Insight drug profile 800007646], teriparatide.See details»